Besold, K; Plachter, B
Recombinant viruses as tools to study human cytomegalovirus immune modulationMed Microbiol Immunol. Bd. 197. H. 2. 2008 S. 215-222
Mersseman, V; Bohm, V; Holtappels, R et al.
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 97-107
Maas, R; Schwedhelm, E; Kahl, L et al.
Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.Clin Chem. Bd. 54. H. 2. 2008 S. 292-300
Holtappels, R; Simon, CO; Munks, MW et al.
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.J Virol. Bd. 82. H. 12. 2008 S. 5781-96
Hahnel, PS; Thaler, S; Antunes, E et al.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906
Sacher, T; Podlech, J; Mohr, CA et al.
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host.Cell Host Microbe. Bd. 3. H. 4. 2008 S. 263-72
Fantini, MC; Dominitzki, S; Rizzo, A et al.
In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells.Nat Protoc. Bd. 2. H. 7. 2007 S. 1789-1794
Graf, C; Heidel, F; Tenzer, S et al.
A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells.Blood. Bd. 109. H. 7. 2007 S. 2985-8
Koslowski, M; Sahin, U; Mitnacht-Kraus, R et al.
A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.Cancer Res. Bd. 67. H. 19. 2007 S. 9528-34
Rotmann, A; Simon, A; Martine, U et al.
Activation of classical protein kinase C decreases transport via systems y+ and y+L.Am J Physiol Cell Physiol. Bd. 292. H. 6. 2007 S. C2259-68